Characterization of 5-fluorouracil microspheres for colonic delivery.
about
In-vivo evaluation in rats of colon-specific microspheres containing 5-fluorouracil.Colorectal cancer targeted Irinotecan-Assam Bora rice starch based microspheres: a mechanistic, pharmacokinetic and biochemical investigation.Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer.The quest for targeted delivery in colon cancer: mucoadhesive valdecoxib microspheres.Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon CancerNucleoside analogue delivery systems in cancer therapy.Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer.Eudragit: a technology evaluation.Exploiting microspheres as a therapeutic proficient doer for colon delivery: a review.Alginate drug delivery systems: application in context of pharmaceutical and biomedical research.Chemoprevention of skin cancer using low HLB surfactant nanoemulsion of 5-fluorouracil: a preliminary study.Preparation of a novel floating ring capsule-type dosage form for stomach specific deliveryRanitidine Hydrochloride-loaded Ethyl Cellulose and Eudragit RS 100 Buoyant Microspheres: Effect of pH Modifiers.Formulation development and evaluation of alginate microspheres of Ibuprofen.Ethyl cellulose and hydroxypropyl methyl cellulose buoyant microspheres of metoprolol succinate: Influence of pH modifiers.Designing colon-specific delivery systems for anticancer drug-loaded nanoparticles: an evaluation of alginate carriers.A pH-triggered delayed-release chronotherapeutic drug delivery system of aceclofenac for effective management of early morning symptoms of rheumatoid arthritis.Development and characterization of novel site specific hollow floating microspheres bearing 5-Fu for stomach targeting.
P2860
Q33379292-0E8D1011-708B-42DD-9E0D-C5B7953EC812Q33403536-4B67BAAC-B86A-4143-B5D5-F27AA6CE3EEAQ34341980-C20D6810-F542-43C1-BEB7-7F50C9D31071Q35072926-88DDB67B-3E77-4228-9B6E-2526029D35B6Q35768392-58C36F7A-2E2F-427B-9989-FD92CCA540BCQ36945847-086C7645-4C98-443D-9654-8F1E63731281Q38017299-66EA3718-9029-4329-8BF3-733ABD2A43A1Q38055849-4C73EF40-115E-4E67-96C9-3B50383119C0Q38073796-90EA4502-5F7A-47AB-93E3-B8DDF8D1F972Q38238527-FD65ED12-0188-4951-827A-9AFBAFD0AD2CQ39042202-37FC67ED-0388-4C72-9770-295004C6A260Q42146534-0D969917-012D-40CB-AF40-BCBAAAF2FB0DQ42406146-9A487096-700A-4BB8-ABB8-234E5FDE888BQ42545697-21D85458-C425-47E3-B5A4-7884DD54C9D5Q42934967-124FAAFA-7627-4DA4-8EFA-3A4EC9940C64Q45893381-0CF39E15-D811-4EC7-807D-BCB987765BEEQ51722724-34D3204D-011F-4682-B2EB-60649D04A307Q53394635-E11D800D-49E8-45AB-9627-E020F735999C
P2860
Characterization of 5-fluorouracil microspheres for colonic delivery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 May 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of 5-fluorouracil microspheres for colonic delivery.
@en
Characterization of 5-fluorouracil microspheres for colonic delivery.
@nl
type
label
Characterization of 5-fluorouracil microspheres for colonic delivery.
@en
Characterization of 5-fluorouracil microspheres for colonic delivery.
@nl
prefLabel
Characterization of 5-fluorouracil microspheres for colonic delivery.
@en
Characterization of 5-fluorouracil microspheres for colonic delivery.
@nl
P2093
P2860
P356
P1433
P1476
Characterization of 5-fluorouracil microspheres for colonic delivery.
@en
P2093
Areeg A A Shamsher
Kanchan Kohli
Mushir Ali
Naseem A Charoo
Roop K Khar
Ziyaur Rahman
P2860
P2888
P356
10.1208/PT070247
P407
P577
2006-05-26T00:00:00Z
P5875
P6179
1018296230